Raccoonpox virus

Last updated

Raccoonpox virus
Virus classification OOjs UI icon edit-ltr.svg
(unranked): Virus
Realm: Varidnaviria
Kingdom: Bamfordvirae
Phylum: Nucleocytoviricota
Class: Pokkesviricetes
Order: Chitovirales
Family: Poxviridae
Genus: Orthopoxvirus
Species:
Raccoonpox virus

Raccoonpox virus (RCN) is a double-stranded DNA virus and a member of the orthopoxviruses in the family Poxviridae and subfamily Chordopoxvirinae. Vertebrates are the natural host of Chordopoxvirinae subfamily viruses. [1] More specifically, raccoons are the natural hosts of RCN. RCN was isolated in 1961 from the upper respiratory tissues of 2 raccoons in a group of 92 observably healthy raccoons (Procyon lotor) trapped close to Aberdeen, Maryland. [2]

Contents

Of the 92 apparently healthy raccoons trapped near Aberdeen, Maryland in 1961, 22 had sera containing RCN HA1 antibodies. The sera partially cross-reacted with a vaccinia virus HA preparation, suggesting a close relation between the viruses. [3] Unlike the HA of other vaccinia-like viruses, the HA of RCN did not cross-react with monkeypox virus HA. [2] Though RPV is a close relative of vaccinia and cowpox viruses, it is distinct enough to be classified as a novel entity in the vaccinia/variola subgroup of poxviruses. [4]

Viral classification

RCN is a double-stranded DNA virus. It is an orthopoxvirus in the family Poxviridae and subfamily Chordopoxvirinae.

Genealogy/ evolution

DNA sequences encoding the HA's of RCN and VV (vaccinia virus) strain WR (western reserve) as well as HA's of VV, RCN, VPX (vole poxvirus), and SKP (skunk poxvirus) are rather divergent. Cross-hybridizations suggest that the HA of RCN, VPX, and SKP are separately diverged and that the HA of VV, ECT (ectromelia virus), VAR (variola virus), and most other orthopoxviruses are closely related. [4] Hybridizations also indicate that orthopoxvirus regulatory sequences flanking the HA ORF are rather conserved. RCN vaccine-laden baits increased antibodies against plague in both antigens. [4]

In contrast to known members of the poxvirus group, RCN is serologically (diagnostic identification of antibodies in serum) unique in its ability to cross-react with a monkeypox agent. [2]

Structure

RCN is an orthopoxvirus. It is an enveloped virus with brick-shaped virion geometries. It has a linear genomic arrangement and monopartite genomic segmentation. [5] It is a large virus particle with a genome of 150 to 300 kbp of dsDNA (Ropp). A hairpin loop exists at either end of the genome. [1] The Guanine/Cytosine (G-C) content of the genome is 35%. There are large regions within the RCN virus genome that cross hybridize between members of the genus. [3]

Differences between terminal region patterns of DNA restriction enzyme digests of different RCN isolates suggest that varied passaging has promoted the advancement of polymorphisms since the virus was first isolated in 1961. [6] RCN tandem repeat sequences found on the terminal Sal1 restriction fragment were found to be distinct from varicella and cowpox virus, lending further support to the claim that RCN is a distinct virus within the orthopoxviruses. [6] In order to distinguish between the orthopoxvirus species and strains of RCN, PCR is used. The distinction is drawn based on the sequences encoding the hemagglutinin (HA) protein. [3]

Genome replication cycle

Entry into Cell: The virion attaches to the cell surface as the viral proteins come into contact with host cell glycosaminoglycan receptors and is taken into the cell through endocytosis. From here it must enter into the cytoplasm. The replication of RCN occurs in the cytoplasm- never in the nucleus. [1]

Replication and Transcription: The replication and transcription of the viral genome occur in the cytoplasm. Genome replication begins with the uncoating of the virus core as it comes into contact with the plasma membrane. Once uncoated, the viral DNA is expressed and replication follows. [1] Replication of the RCN genome occurs through the strand displacement method.

Assembly and Release: Viral assembly occurs in the cytoplasm. The release of the mature virus particle always results in lysing of the host cell. [1]

Modulation of host processes

RCN has a negative effect on the mRNA synthesis of the host cell. [1]

Identification

RCN isolated from 2 of 92 raccoons in Maryland, proposed to be an orthopoxvirus when it was noted that a RCN hemagglutinin preparation reacted with VV (vaccinia virus) hyperimmune rabbit serum. However, it was later reported that sera from 22 of the raccoons reacted highly with a RCN hemagglutinin preparation, but hemagglutinin preparations of VV or monkeypox virus (MPV) showed little or no cross-reactivity. [4]

Identify via agglutination with cardiolipin sensitive chicken erythrocytes. [2]

Associated disease

RCN infected Strain 143 human osteosarcoma cells produce cytoplasmic A-type inclusions (ATIs) where a number of mature virions are lodged to maintain viral infectivity even if the cell lyses. [7]

Pathogenesis

Cell lines infected with RCN, volepox virus (VPX), or skunk poxvirus (SKP), and other orthopoxviruses that are all HAD+ (hemagglutinating viruses based on adherence to erythrocytes to infected cells), form large syncytia (multinucleated cells that can result from the fusion of uninuclear cells), suggest that, conformationally, distinct functional HA's influence polykaryocytosis (process of fusion). [4]

RCN has cytopathic effects (CPE) in monkey kidney tissue cultures (MKTC). Seen on 11h day of incubation, characterized by rounding and granular appearance of cells. [2] When inoculated on the chorioallantoic membrane (CAM) of 12-day embryonated hens’ eggs, the RCN produced many small discrete embedded poxes. [2]

Tropism

Raccoon poxvirus has been shown to infect Strain 143 human osteosarcoma cells grown in monolayer culture, producing A-type inclusions in the cytoplasm as is typical of poxviruses in later multiplication cycles. [8]

To date, most oral vaccines cannot withstand the alimentary tract or do not elicit strong mucosal immune response. Poxviruses are good candidates for the development of wildlife vaccines. They infect mucosal tissue and retain stability when disrupted by the environment. [9]

Use

RCN has been developed as a recombinant for the delivery of vaccines against the plague (caused by bacterium Yersinia pestis ), feline panleukopenia virus, rabies virus and other pathogens in wildlife and domestic animals. [9] Controlling diseases such as the plague in wildlife and domestic animals is important to reducing its transmission to humans. [9]

RCN is favored as a vector for wildlife and veterinary management over other potential poxvirus vectors because it triggers an immune response when it is taken in through mucosal routes, which is important for the widespread immunization of wildlife. [10] Recombinant RCN (rRCN) vaccines been given to a number of mammalian species such as mice, raccoons, cats and sheep without side effects. [10] [11] The rRCN rabies virus glycoprotein recombinant vaccine was effective when given to sheep both intradermally and intramuscularly. [12] Fortunately, the rRCN vaccine did relatively little harm to sheep when ingested orally, suggesting that rRCN vaccines used for wildlife management delivered as oral baits would be safe if accidentally ingested by sheep. [12] Further studies are needed to determine the effect of ingestion of oral bait rRCN vaccines by non-target farm and domestic animals. Particular rRCN vaccines have been designed to effectively confer protective immunity against multiple pathogens. rRCN vaccines have been successful too in treating rabies virus in mice. [11] These vaccines functioned by either expressing the rabies virus internal structural nucleoprotein (RCN-N) or by expressing the rabies virus glycoprotein (RCN-G). [11]

RCN, and all poxviridae viruses, are especially useful in creating vaccines because they create cost-effective, stable, multivalent vaccines that are easy to manufacture, and can be administered through multiple routes. [1] It is believed that RCN vaccination triggers action from both the humoral and cell mediated immune responses and that this immunity is long term after only one vaccination. [1]

Poxvirus recombinant vectors have been implemented to successfully vaccinate against heterologous bacterial, viral, and parasitic pathogens upon use in animals (e.g. raccoons) and humans. [13]

Uses in veterinary medicine: have potential use for this treatment technique in infectious disease, ex vivo therapies, and cancer immunotherapy. *Under clinical trials as well as some licensed commercialization at time of publication. [13]

RCN viral vectors have the potential to replace expensive and labor-intensive pesticide applications in disease prevention. [14]

Recombinant RCN vaccine promote effective immunity against plague (Y. pestis) via the oral route, could provide a practical, alternative approach, although more work is needed to determine the timing of vaccine, the duration of immunity provided, and the effects on nontarget animals. [14]

RCN recombinants expressing rabies virus glycoprotein or nucleoprotein were created. Promoting rabies virus neutralizing antibodies in raccoons, dogs, cotton rats, rabbits, bobcats, and foxes; sometimes at lethal doses. [15]

RCN is used as an oral delivery system for fraction 1 (F1) capsular antigen of Y. pestis. (replacement of thymidine kinase (TK)). RCN was successful in 50% of voluntary participants allowing them to survive subsequent challenges. RCN-vectored vaccine with the LcrV (V) gene, which can also provide protection against Y. pestis. [9]

Related Research Articles

<span class="mw-page-title-main">DNA vaccine</span> Vaccine containing DNA

A DNA vaccine is a type of vaccine that transfects a specific antigen-coding DNA sequence into the cells of an organism as a mechanism to induce an immune response.

<span class="mw-page-title-main">Vaccinia</span> Strain of poxvirus

The vaccinia virus is a large, complex, enveloped virus belonging to the poxvirus family. It has a linear, double-stranded DNA genome approximately 190 kbp in length, which encodes approximately 250 genes. The dimensions of the virion are roughly 360 × 270 × 250 nm, with a mass of approximately 5–10 fg. The vaccinia virus is the source of the modern smallpox vaccine, which the World Health Organization (WHO) used to eradicate smallpox in a global vaccination campaign in 1958–1977. Although smallpox no longer exists in the wild, vaccinia virus is still studied widely by scientists as a tool for gene therapy and genetic engineering.

<span class="mw-page-title-main">Rabies virus</span> Species of virus

Rabies virus, scientific name Rabies lyssavirus, is a neurotropic virus that causes rabies in animals, including humans. It can cause violence, hydrophobia, and fever. Rabies transmission can also occur through the saliva of animals and less commonly through contact with human saliva. Rabies lyssavirus, like many rhabdoviruses, has an extremely wide host range. In the wild it has been found infecting many mammalian species, while in the laboratory it has been found that birds can be infected, as well as cell cultures from mammals, birds, reptiles and insects. Rabies is reported in more than 150 countries and on all continents except Antarctica. The main burden of disease is reported in Asia and Africa, but some cases have been reported also in Europe in the past 10 years, especially in returning travellers.

<i>Poxviridae</i> Family of viruses

Poxviridae is a family of double-stranded DNA viruses. Vertebrates and arthropods serve as natural hosts. There are currently 83 species in this family, divided among 22 genera, which are divided into two subfamilies. Diseases associated with this family include smallpox.

Modified vaccinia Ankara (MVA) is an attenuated (weakened) strain of the vaccinia virus. It is being used as a vaccine against smallpox and mpox, having fewer side effects than smallpox vaccines derived from other poxviruses.

Orthopoxvirus is a genus of viruses in the family Poxviridae and subfamily Chordopoxvirinae. Vertebrates, including mammals and humans, and arthropods serve as natural hosts. There are 12 species in this genus. Diseases associated with this genus include smallpox, cowpox, horsepox, camelpox, and mpox. The most widely known member of the genus is Variola virus, which causes smallpox. It was eradicated globally by 1977, through the use of Vaccinia virus as a vaccine. The most recently described species is the Alaskapox virus, first isolated in 2015.

<span class="mw-page-title-main">Viral vector</span> Biotechnology to deliver genetic material into a cell

Viral vectors are modified viruses designed to deliver genetic material into cells. This process can be performed inside an organism or in cell culture. Viral vectors have widespread applications in basic research, agriculture, and medicine.

<i>Molluscum contagiosum virus</i> Species of virus

Molluscum contagiosum virus (MCV) is a species of DNA poxvirus that causes the human skin infection molluscum contagiosum. Molluscum contagiosum affects about 200,000 people a year, about 1% of all diagnosed skin diseases. Diagnosis is based on the size and shape of the skin lesions and can be confirmed with a biopsy, as the virus cannot be routinely cultured. Molluscum contagiosum virus is the only species in the genus Molluscipoxvirus. MCV is a member of the subfamily Chordopoxvirinae of family Poxviridae. Other commonly known viruses that reside in the subfamily Chordopoxvirinae are variola virus and monkeypox virus.

<i>Murine respirovirus</i> Sendai virus, virus of rodents

Murine respirovirus, formerly Sendai virus (SeV) and previously also known as murine parainfluenza virus type 1 or hemagglutinating virus of Japan (HVJ), is an enveloped, 150-200 nm–diameter, negative sense, single-stranded RNA virus of the family Paramyxoviridae. It typically infects rodents and it is not pathogenic for humans or domestic animals.

<span class="mw-page-title-main">Canarypox</span> Viral disease of birds

Canarypox virus (CNPV) is an Avipoxvirus and etiologic agent of canarypox, a disease of wild and captive birds that can cause significant losses. Canarypox can enter human cells, but it cannot survive and multiply in human cells. There is a live viral vaccine available which may have beneficial properties against human cancer when used as a mammalian expression vector.. Furthermore, the Poximune C vaccine does offer direct protection against CNPV in susceptible birds.

Turkeypox virus is a virus of the family Poxviridae and the genus Avipoxvirus that causes turkeypox. It is one of the most common diseases in the wild turkey population. Turkeypox, like all avipoxviruses, is transmitted either through skin contact or by arthropods acting as mechanical vectors.

<span class="mw-page-title-main">Rabies vaccine</span> Vaccines to prevent rabies in humans and animals

The rabies vaccine is a vaccine used to prevent rabies. There are several rabies vaccines available that are both safe and effective. Vaccinations must be administered prior to rabies virus exposure or within the latent period after exposure to prevent the disease. Transmission of rabies virus to humans typically occurs through a bite or scratch from an infectious animal, but exposure can occur through indirect contact with the saliva from an infectious individual.

Pseudotyping is the process of producing viruses or viral vectors in combination with foreign viral envelope proteins. The result is a pseudotyped virus particle, also called a pseudovirus. With this method, the foreign viral envelope proteins can be used to alter host tropism or increase or decrease the stability of the virus particles. Pseudotyped particles do not carry the genetic material to produce additional viral envelope proteins, so the phenotypic changes cannot be passed on to progeny viral particles. In some cases, the inability to produce viral envelope proteins renders the pseudovirus replication incompetent. In this way, the properties of dangerous viruses can be studied in a lower risk setting.

Enzo Paoletti was an Italian-American virologist who developed the technology to express foreign antigens in vaccinia and other poxviruses. This advance led to the development of vaccines against multiple disease-causing pathogens.

MVA-B, or Modified Vaccinia Ankara B, is an HIV vaccine created to give immune resistance to infection by the human immunodeficiency virus. It was developed by a team of Spanish researchers at the Spanish National Research Council's Biotechnology National Centre headed by Dr. Mariano Esteban. The vaccine is based on the Modified vaccinia Ankara (MVA) virus used during the 1970s to help eradicate the smallpox virus. The B in the name "refers to HIV-B, the most common HIV subtype in Europe". It has been stated by Dr. Esteban that, in the future, the vaccine could potentially reduce the virulence of HIV to a "minor chronic infection akin to herpes".

<span class="mw-page-title-main">Monkeypox virus</span> Species of double-stranded DNA virus

The monkeypox virus is a species of double-stranded DNA virus that causes mpox disease in humans and other mammals. It is a zoonotic virus belonging to the Orthopoxvirus genus, making it closely related to the variola, cowpox, and vaccinia viruses. MPV is oval, with a lipoprotein outer membrane. The genome is approximately 190 kb. Smallpox and monkeypox viruses are both orthopoxviruses, and the smallpox vaccine is effective against mpox if given within 3–5 years before the disease is contracted. Symptoms of mpox in humans include a rash that forms blisters and then crusts over, fever, and swollen lymph nodes. The virus is transmissible between animals and humans by direct contact to the lesions or bodily fluids. The virus was given the name monkeypox virus after being isolated from monkeys, but most of the carriers of this virus are smaller mammals.

Roselyn J. Eisenberg is a professor at The University of Pennsylvania and a member of the University's School of Veterinary Medicine and School of Dental Medicine. The majority of Eisenberg's research is focused on the herpes simplex virus and the poxvirus and how they enter into susceptible cells. She also studies glycoproteins, vaccines, virology and microbiology.

Bernard Moss is a virologist at the National Institute of Allergy and Infectious Diseases, part of the United States National Institutes of Health. He is the Chief of the NIAID Laboratory of Viral Diseases and of the NIAID Genetic Engineering Section. He is known for his work on poxviruses.

B13R is a protein expressed by vaccinia virus.

<span class="mw-page-title-main">Viral vector vaccine</span> Type of vaccine

A viral vector vaccine is a vaccine that uses a viral vector to deliver genetic material (DNA) that can be transcribed by the recipient's host cells as mRNA coding for a desired protein, or antigen, to elicit an immune response. As of April 2021, six viral vector vaccines, four COVID-19 vaccines and two Ebola vaccines, have been authorized for use in humans.

References

  1. 1 2 3 4 5 6 7 8 Pastoret, P. P., & Vanderplasschen, A. (2003). Poxviruses as vaccine vectors [Electronic version]. Comparative Immunology, Microbiology, and Infectious Diseases, 26, 343-355.
  2. 1 2 3 4 5 6 Alexander, A. D.; Flyger, V.; Herman, Y. F.; Mcconnell, S. J.; Rothstein, N.; Yager, R. H. (1972). "Survey Of Wild Mammals In A Chesapeake Bay Area For Selected Zoonoses". Journal of Wildlife Diseases. 8 (2): 119–126. doi: 10.7589/0090-3558-8.2.119 . PMID   4336527.
  3. 1 2 3 Cavallaro, K. F.; Esposito, J. J. (1992). "Sequences of the raccoon poxvirus hemagglutinin protein". Virology. 190 (1): 434–439. doi:10.1016/0042-6822(92)91229-n. PMID   1529542.
  4. 1 2 3 4 5 Rockea, Tonie; Iams, Keith; Dawe, Sandra; Smith, Susan; Williamson, Judy; Heisey, Dennis; Osorio, Jorge (29 October 2009). "Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis)". Vaccine. 28 (2): 338–344. doi:10.1016/j.vaccine.2009.10.043. PMID   19879228.
  5. ↑ "Orthopoxvirus". ViralZone. Retrieved 12 December 2015.
  6. 1 2 Ropp, Susan; Jin, Qi; Knight, Janice; Massung, Robert; Esposito, Joseph (1995). "PCR Strategy for Identification and Differentiation of Smallpox and Other Orthopoxviruses" (PDF). Journal of Clinical Microbiology. 33 (8): 2069–2076. doi:10.1128/jcm.33.8.2069-2076.1995. PMC   228337 . PMID   7559950.
  7. ↑ Knight, Janice; Goldsmith, Cynthia; Tamin, Azaivi; Regnery, Russell; Regnery, David; Esposito, Joseph (1992). "Further Analyses of the Orthopoxviruses Volepox Virus and Raccoon Poxvirus". Virology. 190 (1): 423–433. doi:10.1016/0042-6822(92)91228-m. PMID   1529541.
  8. ↑ Howard, A. R.; Moss, B. (May 2012). "Formation of Orthopoxvirus Cytoplasmic A-Type Inclusion Bodies and Embedding of Virions Are Dynamic Processes Requiring Microtubules". Journal of Virology. 86 (10): 5905–5914. doi:10.1128/JVI.06997-11. PMC   3347259 . PMID   22438543.
  9. 1 2 3 4 Rocke, Tonie; Pussini, Nicola; Smith, Susan; Williamson, Judy; Powell, Bradford; Osorio, Jorge (16 February 2010). "Consumption of Baits Containing Raccoon Pox-Based Plague Vaccines Protects Black-Tailed Prairie Dogs (Cynomys ludovicianus)". Vector-Borne and Zoonotic Diseases. 10 (1): 53–58. doi:10.1089/vbz.2009.0050. PMID   20158332.
  10. 1 2 Orsorio; Powell; Frank; Moss; Haanes; Smith; Rocke; Stinchcomb (2002). "Recombinant raccoon pox vaccine protects mice against lethal plague". Vaccine. 21 (11–12): 1232–1238. doi:10.1016/s0264-410x(02)00557-1. PMID   12559803.
  11. 1 2 3 Lodmell, Donald; Sumner, John; Esposito, Joseph; Bellini, William; Ewalt, Larry (18 March 1991). "Raccoon Poxvirus Recombinants Expressing the Rabies Virus Nucleoprotein Protect Mice against Lethal Rabies Virus Infection". Journal of Virology. 65 (6): 3400–3405. doi:10.1128/JVI.65.6.3400-3405.1991. PMC   241005 . PMID   2033678.
  12. 1 2 DeMartini, J. C.; Bickle, H. M.; Brodie, S. J.; He, B. X.; Esposito, J. J. (2 May 1993). "Raccoon poxvirus rabies virus glycoprotein recombinant vaccine in sheep". Archives of Virology. 133 (1–2): 211–222. doi: 10.1007/bf01309757 . PMID   8240013. S2CID   19453576.
  13. 1 2 Paoletti, Enzo (1996). "Applications of pox virus vectors to vaccination: An update". Proceedings of the National Academy of Sciences. 93 (21): 11349–11353. Bibcode:1996PNAS...9311349P. doi: 10.1073/pnas.93.21.11349 . PMC   38060 . PMID   8876138.
  14. 1 2 Patel, D. D.; Pickup, D. J.; Koklik, W. K. (1985). "Isolation of Cowpox Virus A-Type Inclusions and Characterization of Their Major Protein Component". Virology. 149 (2): 174–189. doi:10.1016/0042-6822(86)90119-4. PMID   3456179.
  15. ↑ Fekadu, Makonnen; Shaddock, John; Sumner, John; Sanderlin, Dane; Knight, Janice; Esposito, Joseph; Baer, George (1991). "Oral Vaccination of Skunks with Raccoon Poxvirus Recombinants Expressing the Rabies Glycoprotein or the Nucleoprotein". Journal of Wildlife Diseases. 27 (4): 681–684. doi:10.7589/0090-3558-27.4.681. PMID   1758034. S2CID   30909913.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.